COMMUNIQUÉS West-GlobeNewswire

ChemoCentryx to Present at Two Upcoming Investor Conferences
03/04/2018
MOUNTAIN VIEW, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]
Bellerophon Therapeutics to Provide Corporate Update at H.C. Wainwright Annual Global Life Sciences Conference
03/04/2018
WARREN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, [...]
BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal
03/04/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
First Choice Healthcare Solutions Reports 2017 Results and Update on Strategic Partnership with Steward Health Care
03/04/2018
MELBOURNE, Fla., April 03, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Status regarding Novo Nordisk's holding of its own shares (31 March 2018)
03/04/2018
Bagsværd, Denmark, 3 April 2018 - In continuation of the company's announcements dated 1 November 2017 and 5 February 2018 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York [...]
Treos Bio Names Gábor Illés as Its Chief Financial Officer
03/04/2018
SAN FRANCISCO and LONDON, April 03, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today [...]
PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year
03/04/2018
DELRAY BEACH, Fla., April 03, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today its financial results [...]
Cellectar Announces Issuance of U.S. Patent Covering CLR 131 Use in Multiple Myeloma
03/04/2018
MADISON, Wis., April 03, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
HealthEC Adds The Villages Health to Population Health Management Solution
03/04/2018
PISCATAWAY, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- HealthEC , which earned the highest overall vendor satisfaction rating in KLAS Research’s 2017 Population Health Management (PHM) Report, announced today that The [...]
Emerald Health Therapeutics Appoints Rebecca Wong as Vice President Quality Affairs
03/04/2018
VICTORIA, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) has appointed Rebecca Wong as Vice President Quality Affairs, with responsibility for [...]
HTG Announces New Patent for Its Technology Issued in Japan
03/04/2018
Patent covers nuclease protection methods for detection of nucleotide variants TUCSON, Ariz., April 03, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and [...]
Pediapharm Announces the Commercial Launch of Cuvposa™ in Canada
03/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, April 03, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE:PDP) (OTCQB:PDDPF) is [...]
Pediapharm annonce le lancement commercial de Cuvposa(MC) au Canada
03/04/2018
N’EST PAS DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS MONTRÉAL, 03 avr. 2018 (GLOBE NEWSWIRE) -- Pediapharm inc. (la « Société » ou « Pediapharm ») (TSX CROISSANCE:PDP) ( [...]
Aeglea BioTherapeutics to Present New Phase 1/2 Trial Results in Arginase 1 Deficiency at the 2018 ACMG Annual Clinical Genetics Meeting
03/04/2018
AUSTIN, Texas, April 03, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
03/04/2018
SAN DIEGO and TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]
Selecta Biosciences to Present Updated Clinical Phase 2 Data of Lead Candidate SEL-212 at the Pan American League of Associations for Rheumatology (PANLAR) Congress on April 10, 2018
03/04/2018
WATERTOWN, Mass., April 03, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Retrophin Initiates Pivotal Phase 3 Clinical Trial of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis
03/04/2018
SAN DIEGO, April 03, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that the first patient has been enrolled in the DUPLEX Study, a global, pivotal Phase 3 clinical trial evaluating the long- [...]
Imagin Medical Announces Private Placement
03/04/2018
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery. The Company’s [...]
Delcath’s PHP Therapy to be Featured in Video Training Session at European Conference of Interventional Oncology
03/04/2018
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that Dr. Brian Steadman, [...]

Pages